Health Ozempic: Managing Type 2 Diabetes and Cardiovascular Risk by Dr Natalie Singh - Health Editor June 27, 2026 by Dr Natalie Singh - Health Editor June 27, 2026 Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes. According to the U.S. Food and Drug Administration (FDA), the medication … 0 FacebookTwitterPinterestEmail